Author

Timothy J. Collier

Michigan State UniversityORCID 0000-0003-0282-8875Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Organism:rat· 2 Assay:electronic health records· 1 Organism:human· 1 Organism:mouse· 1 Organism:non-human primate· 1

Frequent Co-Authors

Caryl E. SortwelliD· 3 shared Kathy Steece‐CollieriD· 3 shared Ivette M. SandovaliD· 2 shared Alix BoomsiD· 1 shared Allyson Cole-Strauss· 1 shared Andreas WeihofeniD· 1 shared Anthony R. WestiD· 1 shared Apoorva Mohan· 1 shared

Activity by Year

2019-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersNeuroscience

Caryl E. SortwellORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

NeuroscienceMuscle & NervePeer-reviewedApr 21, 2025

The Impact of Brain-Derived Neurotrophic Factor rs6265 (Val66Met) Polymorphism on Therapeutic Electrical Stimulation for Peripheral Nerve Regeneration: A Preclinical Study of Therapy-Genotype Interactions

Jordan B. Walters, Maria J. Quezada, Suning He…·Colin K. Franz

This study examines how the rs6265 polymorphism affects the effectiveness of therapeutic electrical stimulation in peripheral nerve regeneration using rat models and human motor neurons.

5 citations

rathuman

𝕏 PostBluesky

NeuroscienceJournal of NeurosciencePeer-reviewedApr 1, 2020

Striatal Nurr1 Facilitates the Dyskinetic State and Exacerbates Levodopa-Induced Dyskinesia in a Rat Model of Parkinson’s Disease

Rhyomi C. Sellnow, Kathy Steece‐Collier, Feras Altwal…·Fredric P. Manfredsson

This study shows that overexpressing Nurr1 in the striatum of rats induces LID and worsens dyskinesia, suggesting Nurr1 as a therapeutic target for Parkinson’s disease.

27 citations

ratexperimental assay

𝕏 PostBluesky

NeurosciencebioRxivPreprintNov 4, 2019

Alpha-synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson’s disease

Tracy A. Cole, Hien Tran Zhao, Timothy J. Collier…·Katrina L. Paumier

This paper demonstrates that antisense oligonucleotides targeting SNCA reduce alpha-synuclein production, prevent pathology, and show translational potential in non-human primates.

10 citations

mousenon-human primate

𝕏 PostBluesky